tiprankstipranks
VistaGen Therapeutics (VTGN)
NASDAQ:VTGN
US Market
VTGN
VistaGen Therapeutics
RESEARCH TOOLSreports
Want to see VTGN full AI Analyst Report?

VistaGen Therapeutics (VTGN) Income Statement

1,159 Followers

VistaGen Therapeutics Income Statement

Last quarter (Q3 2026), VistaGen Therapeutics's total revenue was $303.00K, an increase of 29.49% from the same quarter last year. In Q3, VistaGen Therapeutics's net income was $-18.90M. See VistaGen Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
$ 486.00K$ 1.06M$ -227.00K$ 1.11M$ 1.09M
Gross Profit
$ 486.00K$ 1.06M$ -227.00K$ 1.11M$ 1.09M
Operating Expenses
$ 56.46M$ 34.09M$ 59.04M$ 48.89M$ 19.02M
Depreciation and Amortization
$ 635.00K$ 568.00K$ 532.00K$ 711.10K$ 477.60K
EBITDA
$ -55.34M$ -32.45M$ -58.74M$ -47.05M$ -17.44M
Operating Income
$ -55.97M$ -33.02M$ -59.27M$ -47.78M$ -17.93M
Other Income/Expenses
$ 4.56M$ 3.66M$ 26.00K$ 19.90K$ 2.20K
Pretax Income
$ -51.41M$ -29.36M$ -59.24M$ -47.76M$ -17.93M
Net Income
$ -51.42M$ -29.36M$ -59.25M$ -47.76M$ -17.93M
Per Share Metrics
Basic EPS
$ -1.67$ -1.52$ -8.51$ -7.38$ -14.74
Diluted EPS
$ -1.67$ -1.52$ -8.51$ -7.38$ -14.74
Weighted Average Shares Outstanding
 30.71M 19.35M 6.96M 6.60M 2.87M
Weighted Average Shares Outstanding (Diluted)
 30.71M 19.35M 6.96M 6.60M 2.87M
Currency in USD

VistaGen Therapeutics Earnings and Revenue History